Facts on Drugs Used in Chemotherapy
Active substance: Epirubicin
Extract from the prescribing information:
"Myocardial toxicity, manifested in its most severe form by potentially fatal congestive heart failure (CHF), may occur either during therapy with epirubicin or months to years after termination of therapy."
"Secondary acute myelogenous leukemia (AML) has been reported in patients with breast cancer treated with anthracyclines, including epirubicin."
The above has been extracted from the Ellence prescribing information on the Pfizer webpages.